Original Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 21, 2011; 17(11): 1434-1441
Published online Mar 21, 2011. doi: 10.3748/wjg.v17.i11.1434
Figure 1
Figure 1 Pathological diagnoses in 1- and 2-mo groups after 7,12-dimethylbenzanthracene implantation. The difference between two groups was statistically significant (P = 0.0488), and there was an increase in the frequency of adenocarcinomas in the 2-mo group compared with the 1-mo group (P = 0.0309). PanIN: Pancreatic intraepithelial neoplasia.